{"hands_on_practices": [{"introduction": "This first practice problem moves beyond simple karyotype descriptions to explore the profound impact of molecular details on clinical outcomes. You will analyze a case of an isochromosome involving a known imprinted region to understand why the parental origin of a chromosomal aberration can be as important as the aberration itself. This exercise hones your clinical reasoning skills by connecting cytogenetics, epigenetic regulation through imprinting, and the principles of genetic counseling.", "problem": "A fetus undergoing prenatal diagnosis is found to have an isochromosome for the long arm of an acrocentric chromosome, described cytogenetically as $i(14q)$. Fluorescence in situ hybridization confirms that long-arm sequences from chromosome $14$ are present in three copies, while short-arm satellite material is reduced, consistent with an isochromosome formed by centromeric misdivision or sister chromatid U-type exchange. The $14q32$ region contains an imprinting control domain that regulates clusters of genes with parent-of-origin specific monoallelic expression. Assume the duplicated long arm in the isochromosome arose from a single parental homolog, so the two $14q$ arms within the isochromosome share the same imprinting marks.\n\nStarting from the following foundational facts and definitions:\n- Genomic imprinting is an epigenetic process in which certain loci are expressed from only one allele depending on whether the allele is inherited from the mother or the father. Imprint marks include differential DNA methylation at imprinting control regions that are established in the parental germline and maintained after fertilization through somatic cell divisions.\n- An isochromosome consists of two identical arms of a single chromosome and typically results in trisomy of the duplicated arm material and monosomy of the lost arm material.\n- A pericentric inversion is an inversion that includes the centromere and can lead to unbalanced recombinant gametes upon meiotic crossing-over within the inversion loop.\n- Uniparental Disomy (UPD) refers to the situation where both homologs (or segments) are inherited from one parent; segmental UPD can arise from structural rearrangements and has parent-of-origin effects in imprinted regions.\n\nWhich option(s) correctly describe how imprinted loci on the duplicated arm could produce parent-of-origin effects in this scenario and derive appropriate genetic counseling implications for an isochromosome that duplicates imprinted regions?\n\nA. Parent-of-origin of the duplicated arm influences phenotype because imprinted loci require one active allele from a specific parent. If the duplicated arm is maternally derived, there will be two maternal and one paternal copies of the imprinted domain; maternally expressed genes may have increased dosage (approximately $2:1$ relative to paternal) and paternally expressed genes may have relatively decreased dosage. Counseling should include laboratory assessment of parental origin (for example, methylation analysis at imprinting control regions) and parental structural testing, since carriers of balanced rearrangements involving chromosome $14$ (for example, Robertsonian translocations of acrocentrics or pericentric inversions spanning the imprinted region) can have increased recurrence risk of offspring with dosage anomalies of the imprinted domain.\n\nB. Parent-of-origin does not affect phenotype because imprint marks are universally erased after fertilization; only total copy number of $14q$ determines the clinical outcome. Therefore, counseling focuses on general trisomy effects, and recurrence risk in future pregnancies is approximately $25\\%$ irrespective of parental karyotypes.\n\nC. If the duplicated arm is paternally derived, the imprinted cluster behaves as if there is segmental paternal uniparental disomy for the duplicated domain, leading to overrepresentation of paternally marked alleles and underrepresentation of maternally marked alleles, with parent-of-origin specific clinical consequences. If both parents have normal karyotypes and methylation profiles, recurrence risk is very low (on the order of $<1\\%$), but if a parent is a Robertsonian translocation carrier involving chromosome $14$ (for example, $rob(14;14)$ or $rob(13;14)$), recurrence risk is substantially increased; thus, counseling should include both parental-origin testing and parental karyotyping.\n\nD. Inversions are irrelevant in imprinting disorders because inversion carriers only produce balanced gametes; therefore, identifying a parental pericentric inversion would not change recurrence risk or counseling when an isochromosome duplicates an imprinted region.\n\nSelect all correct options.", "solution": "This problem has been validated as scientifically sound, well-posed, and objective, allowing for a direct derivation of the solution. The scenario requires an analysis of the consequences of an isochromosome involving an imprinted chromosomal region, focusing on parent-of-origin effects and their implications for genetic counseling.\n\nA fetus with one normal chromosome 14 and an isochromosome $i(14q)$ has three copies of the long arm, $14q$. The problem states that the two $14q$ arms on the isochromosome are identical and derived from a single parent. The $14q32$ region is subject to genomic imprinting, meaning gene expression is dependent on parental origin.\n\n**Analysis of Parent-of-Origin Effects:**\n- **Maternal Origin of $i(14q)$:** The fetus has one normal paternal chromosome 14 and a maternal $i(14q)$. This results in a genetic makeup of one paternal $14q$ and two maternal $14q$ arms. For imprinted genes in the $14q32$ region, this leads to an abnormal dosage. Maternally expressed genes will have two active copies (from the maternal $i(14q)$) and paternally expressed genes will have one active copy (from the paternal chromosome 14). This imbalance causes a specific clinical phenotype (resembling Temple syndrome).\n- **Paternal Origin of $i(14q)$:** The fetus has one normal maternal chromosome 14 and a paternal $i(14q)$. This results in a makeup of one maternal $14q$ and two paternal $14q$ arms. Paternally expressed genes will have two active copies, while maternally expressed genes will have one. This distinct imbalance leads to a different clinical phenotype (resembling Kagami-Ogata syndrome).\nThis confirms that the parental origin of the isochromosome is critical for the phenotype.\n\n**Analysis of Recurrence Risk and Genetic Counseling:**\n- The recurrence risk depends on whether the event is *de novo* or inherited.\n- If both parents have normal karyotypes, the $i(14q)$ likely arose from a sporadic error during meiosis or post-zygotically. In this case, the recurrence risk is very low ($<1\\%$).\n- If a parent carries a balanced structural rearrangement involving chromosome 14, the risk can be significantly higher. Such rearrangements predispose to meiotic malsegregation, leading to unbalanced gametes.\n    - A **Robertsonian translocation** involving chromosome 14 (e.g., $rob(13;14)$ or the homologous $rob(14;14)$) can lead to gametes with an incorrect number of chromosome 14 copies.\n    - A **pericentric inversion** of chromosome 14 can lead to the production of unbalanced recombinant gametes if a crossover occurs within the inverted loop. These gametes would have duplications and deletions of $14q$ segments.\nTherefore, comprehensive genetic counseling requires both determining the parental origin of the $i(14q)$ (for prognosis) and performing parental karyotyping (for recurrence risk).\n\n**Evaluation of the Options:**\n- **Option A:** Correctly states that phenotype depends on parental origin and accurately describes the molecular consequences of a maternally derived $i(14q)$. It correctly identifies that counseling must include parental origin testing and parental structural testing (including for Robertsonian translocations and pericentric inversions) to assess recurrence risk. This statement is entirely correct.\n- **Option B:** Incorrectly claims that imprints are erased after fertilization and that parent-of-origin does not matter. It also provides an arbitrary and incorrect recurrence risk.\n- **Option C:** Correctly describes the consequences of a paternally derived $i(14q)$ as segmental paternal UPD. It accurately contrasts the low recurrence risk for *de novo* cases with the high risk associated with a parental Robertsonian translocation carrier. The conclusion that counseling requires both parental origin testing and karyotyping is correct.\n- **Option D:** Incorrectly claims that inversion carriers produce only balanced gametes. Pericentric inversion carriers are at risk of producing unbalanced recombinant gametes, making parental screening for such inversions highly relevant to recurrence risk assessment.\n\nBased on this analysis, options A and C are correct descriptions of the genetic principles and counseling implications.", "answer": "$$\\boxed{AC}$$", "id": "5051361"}, {"introduction": "Now we bridge the gap between theoretical cytogenetics and the quantitative data produced in a modern genetics laboratory. This problem asks you to model the signal from an array-based comparative genomic hybridization (aCGH) experiment on a mosaic sample containing an isochromosome. By working backwards from the observed data, you will develop a practical understanding of how diagnostic tools can reveal not just the presence of a chromosomal abnormality, but also its prevalence within a tissue.", "problem": "A patient’s tumor specimen is analyzed by array-based comparative genomic hybridization (aCGH), which reports the logarithm base two of the ratio of test to reference signal, approximating the ratio of test to reference copy number at each genomic locus. The specimen is a mosaic mixture: a fraction $f$ of cells carry an isochromosome of the long arm $i(q)$, and the remaining fraction $1-f$ are cytogenetically normal diploid. In the cells carrying the isochromosome $i(q)$, the short arm ($p$) is present in $1$ copy and the long arm ($q$) is present in $3$ copies, whereas normal cells have $2$ copies for both arms. A paracentric inversion confined to the $q$ arm in the abnormal clone is also present, but inversions are copy-number neutral and do not change aCGH amplitudes; you may ignore any local breakpoint effects and treat arm-level medians as representative.\n\nThe aCGH platform yields the following arm-level median log base two ratios: $L_p=-0.321928094$ for the $p$ arm and $L_q=0.263034406$ for the $q$ arm.\n\nUsing only the following fundamental bases:\n- The aCGH log base two ratio at a locus equals $\\log_{2}$ of the fold-change in expected copy number relative to a normal diploid reference of $2$ copies.\n- In a mosaic mixture, the expected copy number at a locus equals the weighted average of copy numbers across the two cellular populations with weights $1-f$ (normal) and $f$ (abnormal).\n- An isochromosome $i(q)$ yields $1$ copy of the $p$ arm and $3$ copies of the $q$ arm in the abnormal cells, while normal cells remain at $2$ copies for both arms.\n\nDerive the expressions for the expected aCGH log base two ratios across the $p$ and $q$ arms as functions of $f$, and then use the observed values $L_p$ and $L_q$ to estimate the mosaic fraction $f$. Report the final value of $f$ as a decimal fraction rounded to three significant figures. Do not use a percent sign.", "solution": "The problem describes a mosaic biological sample and asks for the derivation of a model for array-based comparative genomic hybridization (aCGH) signals, followed by an estimation of the mosaic fraction using provided data. The validation process confirms the problem is scientifically sound, well-posed, and objective. We can therefore proceed with the solution.\n\nFirst, we define the relevant variables and constants based on the problem statement.\nLet $f$ be the fraction of cells carrying the isochromosome $i(q)$, where $0 \\le f \\le 1$.\nThe fraction of cytogenetically normal diploid cells is therefore $1-f$.\n\nThe copy numbers (CN) for the short arm ($p$) and long arm ($q$) in each cell population are given:\n- In normal cells (subscript 'n'): $CN_{p,n} = 2$ and $CN_{q,n} = 2$.\n- In abnormal cells with $i(q)$ (subscript 'a'): $CN_{p,a} = 1$ and $CN_{q,a} = 3$.\n\nThe expected copy number for each arm in the bulk tumor specimen is the weighted average of the copy numbers of the two populations.\nFor the $p$ arm, the expected copy number, $\\langle CN_p \\rangle$, is:\n$$ \\langle CN_p \\rangle = f \\cdot CN_{p,a} + (1-f) \\cdot CN_{p,n} $$\nSubstituting the given values:\n$$ \\langle CN_p \\rangle = f(1) + (1-f)(2) = f + 2 - 2f = 2 - f $$\nFor the $q$ arm, the expected copy number, $\\langle CN_q \\rangle$, is:\n$$ \\langle CN_q \\rangle = f \\cdot CN_{q,a} + (1-f) \\cdot CN_{q,n} $$\nSubstituting the given values:\n$$ \\langle CN_q \\rangle = f(3) + (1-f)(2) = 3f + 2 - 2f = 2 + f $$\n\nThe aCGH platform reports the logarithm base two of the ratio of the test copy number to a reference copy number, which is $2$ for a diploid reference. Let $L_p$ and $L_q$ be the log-ratios for the $p$ and $q$ arms, respectively.\nThe expression for the log-ratio of the $p$ arm as a function of $f$ is:\n$$ L_p(f) = \\log_{2}\\left( \\frac{\\langle CN_p \\rangle}{2} \\right) = \\log_{2}\\left( \\frac{2-f}{2} \\right) = \\log_{2}\\left( 1 - \\frac{f}{2} \\right) $$\nSimilarly, the expression for the log-ratio of the $q$ arm as a function of $f$ is:\n$$ L_q(f) = \\log_{2}\\left( \\frac{\\langle CN_q \\rangle}{2} \\right) = \\log_{2}\\left( \\frac{2+f}{2} \\right) = \\log_{2}\\left( 1 + \\frac{f}{2} \\right) $$\nThese two equations are the derived expressions for the expected aCGH log base two ratios as functions of $f$.\n\nNext, we use the observed experimental values, $L_p = -0.321928094$ and $L_q = 0.263034406$, to estimate $f$. We can solve for $f$ using either equation.\n\nUsing the equation for the $p$ arm:\n$$ -0.321928094 = \\log_{2}\\left( 1 - \\frac{f}{2} \\right) $$\nTo solve for $f$, we exponentiate both sides with base $2$:\n$$ 2^{-0.321928094} = 1 - \\frac{f}{2} $$\nThe left-hand side evaluates to approximately $0.8$.\n$$ 0.8 = 1 - \\frac{f}{2} $$\nRearranging the terms to solve for $f$:\n$$ \\frac{f}{2} = 1 - 0.8 = 0.2 $$\n$$ f = 2 \\times 0.2 = 0.4 $$\n\nTo ensure consistency of the model and the data, we perform an independent calculation using the data for the $q$ arm:\n$$ 0.263034406 = \\log_{2}\\left( 1 + \\frac{f}{2} \\right) $$\nExponentiating both sides with base $2$:\n$$ 2^{0.263034406} = 1 + \\frac{f}{2} $$\nThe left-hand side evaluates to approximately $1.2$.\n$$ 1.2 = 1 + \\frac{f}{2} $$\nRearranging the terms:\n$$ \\frac{f}{2} = 1.2 - 1 = 0.2 $$\n$$ f = 2 \\times 0.2 = 0.4 $$\nBoth measurements provide a consistent estimate of $f = 0.4$. The problem requires the answer to be stated as a decimal fraction rounded to three significant figures.\n\nThe value $0.4$ expressed to three significant figures is $0.400$.", "answer": "$$\\boxed{0.400}$$", "id": "5051432"}, {"introduction": "This final exercise challenges you to synthesize multiple genetic concepts into a single predictive model for a complex phenotype. Starting with a hypothetical cell line containing both an isochromosome and a pericentric inversion, you will calculate the expected number of clinical features based on principles of gene dosage, penetrance, and probability. This practice demonstrates how geneticists integrate information about chromosomal structure, gene function, and inheritance patterns to forecast the clinical consequences of complex rearrangements.", "problem": "A diploid human cell line carries an isochromosome of the long arm for a single autosome. An isochromosome is defined as a structurally abnormal chromosome with two identical arms produced by transverse misdivision at the centromere, yielding two copies of one arm and loss of the other arm. Assume that for this chromosome, all genes on the long arm ($q$ arm) are present in $3$ copies per cell and all genes on the short arm ($p$ arm) are present in $1$ copy per cell. Further assume the standard gene dosage model that, to first approximation, messenger ribonucleic acid abundance scales linearly with gene copy number relative to the diploid baseline of $2$ copies, and that dosage-sensitive phenotypes arise when triplosensitive or haploinsufficient loci experience $3$ or $1$ copies, respectively.\n\nIn addition, the isochromosome harbors a pericentric inversion, defined as a chromosomal inversion including the centromere, spanning a fraction $f$ of the $q$ arm’s physical length. For any triplosensitive locus that lies within the inversion span, one of the two $q$-arm copies on the isochromosome is disrupted at that locus, rendering that locus effectively present in $2$ functional copies rather than $3$ and thus not triplosensitive in effect. Assume that triplosensitive loci are uniformly distributed along the $q$ arm, so that the expected fraction of triplosensitive loci affected by the inversion equals $f$.\n\nFor this chromosome:\n- there are $T_q = 18$ known triplosensitive loci on the $q$ arm,\n- there are $H_p = 7$ known haploinsufficient loci on the $p$ arm,\n- the inversion spans fraction $f = 0.25$ of the $q$ arm.\n\nAssume that each triplosensitive locus present in $3$ functional copies manifests a phenotype with per-locus penetrance $\\alpha = 0.7$, and each haploinsufficient locus present in $1$ copy manifests a phenotype with per-locus penetrance $\\beta = 0.4$. Treat locus-specific phenotypic contributions as distinct, and use linearity of expectation to compute the expected total number of dosage-sensitive phenotypes manifested in a carrier of this isochromosome with the given inversion.\n\nWhat is this expected number? Express your final answer as a single real number. No units are required. Do not round unless necessary; an exact decimal is acceptable.", "solution": "The problem statement has been critically validated and is deemed valid. It is scientifically grounded in established principles of medical genetics and cytogenetics, well-posed with all necessary information provided, and objective in its language. The model, while simplified, is internally consistent and allows for a unique, meaningful solution.\n\nThe goal is to calculate the expected total number of dosage-sensitive phenotypes. The problem states that we should use the linearity of expectation. The total number of phenotypes is the sum of phenotypes arising from haploinsufficient loci and those arising from triplosensitive loci. Let $E_{total}$ be the total expected number of phenotypes. We can write:\n$$\nE_{total} = E_{H} + E_{T}\n$$\nwhere $E_{H}$ is the expected number of phenotypes from haploinsufficient loci and $E_{T}$ is the expected number of phenotypes from triplosensitive loci.\n\nFirst, let's analyze the contribution from haploinsufficient loci. The cell contains one normal copy of the autosome (with one short $p$ arm and one long $q$ arm) and one isochromosome of the long arm, i(q) (with two $q$ arms and zero $p$ arms). Therefore, the total number of $p$ arms in the cell is $1$. All genes on the $p$ arm are present in a single copy, confirming the statement that they are present in $1$ copy per cell. Loci that cause a phenotype when present in only one copy are termed haploinsufficient.\n\nThe problem provides the following givens for haploinsufficient loci:\n- The number of known haploinsufficient loci on the $p$ arm is $H_p = 7$.\n- Each of these $H_p$ loci is present in $1$ copy.\n- The per-locus penetrance for a phenotype at $1$ copy is $\\beta = 0.4$.\n\nThe expected number of phenotypes from a single haploinsufficient locus is equal to its probability of manifesting, which is its penetrance, $\\beta$. By the linearity of expectation, the total expected number of phenotypes from all $H_p$ haploinsufficient loci is the sum of their individual expectations:\n$$\nE_{H} = \\sum_{i=1}^{H_p} \\beta = H_p \\times \\beta\n$$\nSubstituting the given values:\n$$\nE_{H} = 7 \\times 0.4 = 2.8\n$$\n\nNext, we analyze the contribution from triplosensitive loci. The total number of $q$ arms in the cell is $1$ (from the normal homolog) plus $2$ (from the isochromosome), for a total of $3$ $q$ arms. Genes on the $q$ arm are thus present in $3$ copies, a condition known as trisomy for that arm. Loci that cause a phenotype when present in three copies are termed triplosensitive.\n\nThe problem avers a complexity: a pericentric inversion on the isochromosome. The relevant givens are:\n- The total number of known triplosensitive loci on the $q$ arm is $T_q = 18$.\n- The inversion spans a fraction $f = 0.25$ of the $q$ arm.\n- For a triplosensitive locus lying within the inversion span, one functional copy is disrupted. This changes the functional gene copy number for that locus from $3$ to $2$.\n- Loci present in $2$ functional copies do not exhibit a triplosensitive phenotype.\n- Triplosensitive loci are assumed to be uniformly distributed along the $q$ arm.\n- The per-locus penetrance for a phenotype at $3$ functional copies is $\\alpha = 0.7$.\n\nDue to the uniform distribution assumption, the expected fraction of triplosensitive loci that fall outside the inversion span is $(1-f)$. Only these loci will have $3$ functional copies and are thus capable of producing a triplosensitive phenotype. The expected number of such \"effective\" triplosensitive loci, let's call it $E[T_{q, \\text{eff}}]$, is:\n$$\nE[T_{q, \\text{eff}}] = T_q \\times (1 - f)\n$$\nSubstituting the given values:\n$$\nE[T_{q, \\text{eff}}] = 18 \\times (1 - 0.25) = 18 \\times 0.75 = 13.5\n$$\nSo, we expect $13.5$ triplosensitive loci to be present in $3$ functional copies.\n\nEach of these effective triplosensitive loci manifests a phenotype with penetrance $\\alpha = 0.7$. The expected number of phenotypes for any single effective triplosensitive locus is $\\alpha$. Applying the linearity of expectation, the total expected number of phenotypes from all triplosensitive loci is the expected number of effective loci multiplied by the penetrance per locus:\n$$\nE_{T} = E[T_{q, \\text{eff}}] \\times \\alpha = (T_q \\times (1 - f)) \\times \\alpha\n$$\nSubstituting the calculated and given values:\n$$\nE_{T} = 13.5 \\times 0.7 = 9.45\n$$\n\nFinally, the total expected number of dosage-sensitive phenotypes is the sum of the expectations from the haploinsufficient and triplosensitive loci:\n$$\nE_{total} = E_{H} + E_{T}\n$$\n$$\nE_{total} = 2.8 + 9.45 = 12.25\n$$\nThe expected total number of dosage-sensitive phenotypes manifested in a carrier is $12.25$.", "answer": "$$\\boxed{12.25}$$", "id": "5051417"}]}